Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Omega Diagnostics Group Plc | LSE:ODX | London | Ordinary Share | GB00B1VCP282 | ORD 4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 2.20 | 2.00 | 2.40 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Nov 2022 to Nov 2024
TIDMCNSL
RNS Number : 5260M
Cambridge Nutritional Sciences PLC
15 September 2023
Omega Diagnostics Group plc
(To be renamed Cambridge Nutritional Sciences PLC)
(the 'Company')
Change of Name
Further to the passing of the relevant resolution at the Company's Annual General Meeting, held 6 September 2023, the Company confirms the change of name to Cambridge Nutritional Sciences plc has now taken place and becomes effective on the London Stock Exchange today.
The Company's TIDM has been updated to CNSL, but its ISIN (GB00B1VCP282), SEDOL (B1VCP28) and LEI (2138007U9P4BTZTYIR92) numbers remain unchanged.
Shareholders should also note that their holdings of ordinary shares in the Company will not be affected by the change of name. Furthermore, existing share certificates should be retained as they remain valid for all purposes and new share certificates will not be issued.
AIM nominated advisor name change
The Company also notes that its nominated adviser and broker finnCap Ltd, has changed its name to Cavendish Capital Markets Limited.
-Ends-
Contacts:
Omega Diagnostics Group PLC (to be renamed Cambridge Nutritional Sciences PLC) www.omegadx.com Jag Grewal, Chief Executive Officer via Walbrook PR Cavendish Capital Markets Limited Tel: 020 7220 0500 Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance) Nigel Birks / Harriet Ward (ECM) Walbrook PR Limited Tel: 020 7933 8780 or omega@walbrookpr.com Paul McManus / Lianne Applegarth Mob: 07980 541 893 / 07584 391 303 Sam Allen Mob: 07502 558 258
About Omega Diagnostics Group PLC (to be renamed Cambridge Nutritional Sciences PLC)
Omega (AIM: ODX, to become CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CANFFFVIATISLIV
(END) Dow Jones Newswires
September 15, 2023 02:00 ET (06:00 GMT)
1 Year Omega Diagnostics Chart |
1 Month Omega Diagnostics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
